HR 1690
107th Congress
House
Export-Import Bank HIV/AIDS Medicine Access Promotion Act
Official title: To amend the Export-Import Bank Act of 1945 to prohibit the Export-Import Bank of the United States from assisting the export of any good or service to or by a… Show full official titleShow less
Official title: To amend the Export-Import Bank Act of 1945 to prohibit the Export-Import Bank of the United States from assisting the export of any good or service to or by any company that is challenging an intellectual property law or government policy of a developing country, which regulates and promotes access to an HIV/AIDS pharmaceutical or medical technology.
Foreign Trade and International Finance
AIDS (Disease)Access to health careCivil actions and liabilityCommerce
More subjectsShow fewer subjects
Credit insuranceDeveloping countriesDrug industryDrugsEconomics and Public FinanceExport creditExport financeFederally-guaranteed loansFinance and Financial SectorGovernment lendingHealthHuman immunodeficiency virusesIntellectual propertyInternational AffairsLaw
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
May 14, 2001
Referred to the Subcommittee on International Monetary Policy and Trade.
May 2, 2001
Referred to the House Committee on Financial Services.
May 2, 2001
Introduced in House
Ask about this bill
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Latest action
Referred to the Subcommittee on International Monetary Policy and Trade.
Plain-English summary
Export-Import Bank HIV/AIDS Medicine Access Promotion Act - Amends the Export-Import Bank Act of 1945 to prohibit the Export-Import Bank of the United States from guaranteeing, insuring, or extending credit in connection with the export of any good or service by or to a restrictive company (or parent or any subsidiary) that: (1) is challenging the validity of a qualified HIV/AIDS access law or policy in a court of law; (2) is a complaining party with respect to the law or policy, pursuant to any provision of the Agreement on Trade-related Aspects of Intellectual Property Rights of the Uruguay Round Agreements Act, or any provision of any other international agreement relating to intellectual property rights; or (3) has made a formal complaint, which has not been withdrawn, to the United States Trade Representative about such law or policy. Defines "qualified HIV/AIDS access law or policy" as a law or government policy of a developing country with respect to intellectual property which has the effect of regulating the use of a pharmaceutical or technology that may be used in the treatment of human immunodeficiency virus (HIV) or acquired immune deficiency syndrome (AIDS), or an associated opportunistic disease, and which promotes access to the pharmaceutical or technology by the population of such country.
Bill text
1 version
- Introduced in House Formatted Text PDF
Committees of jurisdiction
2
Cosponsors
3
Cite this page
U.S. Congress. (2026). H.R. 1690: Export-Import Bank HIV/AIDS Medicine Access Promotion Act. 107th Congress. Open America. https://openamerica.io/bill/107-HR-1690/
"H.R. 1690: Export-Import Bank HIV/AIDS Medicine Access Promotion Act." 107th Congress, 2026, Open America, https://openamerica.io/bill/107-HR-1690/.
H.R. 1690, 107th Cong. (2026), https://openamerica.io/bill/107-HR-1690/.
[H.R. 1690: Export-Import Bank HIV/AIDS Medicine Access Promotion Act](https://openamerica.io/bill/107-HR-1690/)